Surface Oncology (NASDAQ:SURF) reported its Q1 earnings results on Thursday, May 4, 2023 at 07:00 AM.
Here’s what investors need to know about the announcement.
Earnings
Surface Oncology beat estimated earnings by 8.33%, reporting an EPS of $-0.33 versus an estimate of $-0.36.
Revenue was down $30.00 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.02 which was followed by a 8.4% drop in the share price the next day.
Here’s a look at Surface Oncology’s past performance:
| Quarter | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|
| EPS Estimate | -0.33 | -0.47 | -0.46 | -0.28 |
| EPS Actual | -0.35 | -0.39 | -0.46 | 0.13 |
| Revenue Estimate | 2.50M | 80K | 100K | 10.48M |
| Revenue Actual | 0 | 0 | 0 | 30.00M |
Listen to the earnings announcement yourself by clicking here.
To track all earnings releases for Surface Oncology visit their earnings calendar here.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
